Big Data Clinical Research Life Science Research 
ACRP blog
APRIL 5, 2023
AI is increasingly important in drug discovery and development as well as clinical trials, operations, pharmacovigilance, and many other areas.” This has led to the emergence of a new ‘pharmaceutical intelligence’ that has allowed the industry to move away from traditional, slow-moving, and costly processes,” Lyons writes. “AI
pharmaphorum
FEBRUARY 1, 2022
Attendees will learn more about how an SCA was used at the design and execution phases in a recent study of new treatments for relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL) and will also receive an eBook ‘How to harness the potential of AI and real-world data for clinical research’. About the panel.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Crucial Data Soutions
NOVEMBER 9, 2021
Here at CDS, we’ve long envisioned the mobile app as an end-to-end solution, encapsulating integral functions from electronic patient-reported outcomes (ePRO) and electronic data capture (EDC) to clinical trial management system (CTMS) and randomization and trial supply management (RTSM). Greater data security.
Drug Discovery World
DECEMBER 20, 2022
As 2022 draws to a close, life sciences market analysts attempt to correctly predict what the next 12 months might bring to the drug discovery sector. There will be greater emphasis on diversity in clinical trials. In summary, 2023 could be a very exciting year for life sciences. M&A activity will accelerate.
pharmaphorum
MAY 25, 2021
Real-world evidence (RWE) is emerging as an important area of research to reveal, in real time, new insights and innovations in medicine. But, until recently, an important data source has been locked up in the electronic health record (EHR), often in the form of unstructured or ‘free’ text entered by healthcare professionals.
Drug Discovery World
FEBRUARY 6, 2023
Johannes Goll, Global Head of Emmes’ Biomedical Data Science and Bioinformatics department, explains how big data analytics can deliver improved therapies and bring clinical research one step close to realising the potential of personalised care.
Drug Discovery World
OCTOBER 12, 2022
DDW sits down with Mark Matson, Senior Solution Specialist for Sensor Cloud at Medidata, a Dassault Systèmes company, about the use of digital biomarkers in life sciences and how they can help advance our understanding of disease. . Companies are using sensors that we can put on our wrist or chest and capture all types of data.
Expert insights. Personalized for you.
52 
Let's personalize your content